Open AccessGuidance of Sentinel Lymph Node Biopsy Decisions In Patients With T1–T2 Melanoma Using Gene Expression Profiling
Author(s) -
John T. Vetto,
Eddy C. Hsueh,
Brian Gastman,
Larry D. Dillon,
Federico A. Monzon,
Robert W. Cook,
Jennifer Keller,
Xin Huang,
Andrew M. Fleming,
Preston W. Hewgley,
Pedram Gerami,
Sancy A. Leachman,
Jeffrey D. Wayne,
Adam C. Berger,
Martin D. Fleming
Publication year - 2019
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2018-0912
Subject(s) - medicine , sentinel lymph node , gene expression profiling , biopsy , melanoma , profiling (computer programming) , oncology , gene expression , pathology , radiology , gene , cancer research , cancer , breast cancer , genetics , operating system , biology , computer science
Can gene expression profiling be used to identify patients with T1-T2 melanoma at low risk for sentinel lymph node (SLN) positivity?
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom